We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back to Event-Details

NCA Showcase: Brexit Implications for the EU27 Network and Decentralised Activities

Track:
Hot Topic/Stand Alone

Day & Time:
April 18, 8:30AM - 10:00AM (Central Europe Standard Time)

Session Number:
S1100

Room Number:
Montreal

Type:
Session

Title:
NCA Showcase: Brexit Implications for the EU27 Network and Decentralised Activities

Chair(s):
Christa Wirthumer-Hoche, PhD
Head; Chair, EMA Management Board
Austrian Medicines and Medical Devices Agency (AGES), Austria

Description:
This session gives the floor to the National Competent Authorities (NCA) to discuss their local progress, burning topics, and stakeholder engagement regarding Brexit.

Presentation(s) & Speaker(s):
Brexit Implications for the HMA Multi-Annual Work Programme
Christa Wirthumer-Hoche, PhD
Head; Chair, EMA Management Board
Austrian Medicines and Medical Devices Agency (AGES), Austria

HMA Brexit Task Force
Hugo Hurts
Executive Director
Medicines Evaluation Board (MEB), Netherlands

Focus on MRP/DCP
Laura Oliveira Santamaria, MPharm
Head of RRAA Division, Human Medicines Department
AEMPS, Spain

How is Industry Preparing?
Virginia Lee Acha, PhD, MSc
Executive Director, Global Regulatory Policy
MSD, United Kingdom

Strengthening and Optimisation of Regulatory Procedures
Stan A van Belkum, MSc
Acting Director
Medicines Evaluation Board, Netherlands